- Home
- CSBR vs USAU Comparison
CSBR vs USAU Comparison
Compare CSBR & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- USAU
- Stock Information
- Founded
- CSBR 1985
- USAU 2014
- Country
- CSBR United States
- USAU United States
- Employees
- CSBR N/A
- USAU N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- USAU Precious Metals
- Sector
- CSBR Health Care
- USAU Basic Materials
- Exchange
- CSBR Nasdaq
- USAU Nasdaq
- Market Cap
- CSBR 123.2M
- USAU 126.8M
- IPO Year
- CSBR 1986
- USAU N/A
- Fundamental
- Price
- CSBR $6.42
- USAU $18.40
- Analyst Decision
- CSBR Strong Buy
- USAU Strong Buy
- Analyst Count
- CSBR 1
- USAU 3
- Target Price
- CSBR $12.00
- USAU $19.00
- AVG Volume (30 Days)
- CSBR 40.7K
- USAU 393.3K
- Earning Date
- CSBR 09-15-2025
- USAU 09-15-2025
- Dividend Yield
- CSBR N/A
- USAU N/A
- EPS Growth
- CSBR N/A
- USAU N/A
- EPS
- CSBR 0.21
- USAU N/A
- Revenue
- CSBR $56,878,000.00
- USAU N/A
- Revenue This Year
- CSBR $9.30
- USAU N/A
- Revenue Next Year
- CSBR $31.17
- USAU N/A
- P/E Ratio
- CSBR $29.53
- USAU N/A
- Revenue Growth
- CSBR 10.11
- USAU N/A
- 52 Week Low
- CSBR $3.75
- USAU $5.44
- 52 Week High
- CSBR $11.99
- USAU $18.20
- Technical
- Relative Strength Index (RSI)
- CSBR 46.30
- USAU 70.74
- Support Level
- CSBR $6.27
- USAU $16.08
- Resistance Level
- CSBR $6.90
- USAU $16.59
- Average True Range (ATR)
- CSBR 0.29
- USAU 0.87
- MACD
- CSBR -0.02
- USAU 0.14
- Stochastic Oscillator
- CSBR 23.37
- USAU 87.41
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.